Jay Parrish

VIR

Jay Parrish serves as Chief Business Officer at Vir Biotechnology, Inc. (VIR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$797.5K

Net Position

Net Seller

$797.5K

Companies Traded

VIR

Active Period

Mar 2021 – Apr 2021

2 total trades

Most Recent

Sell VIR

Apr 5, 2021 · $357.0K

Jay Parrish's Insider Trading at Vir Biotechnology, Inc. (VIR)

Buys

0 · $0.00

Sells

2 · $797.5K

Total Shares Bought

Total Shares Sold

13,888

VIR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 5, 2021↗	Sell	6,944	$51.40	$357.0K	9,260
Mar 3, 2021↗	Sell	6,944	$63.44	$440.5K	9,260

Related Insiders

SATO VICKI L

director

VIRSell · Mar 3, 2026

Mark Eisner

officer: EVP and Chief Medical Officer

VIRSell · Feb 26, 2026

Backer Marianne De

director, officer: Chief Executive Officer

VIRSell · Feb 26, 2026

Mark Eisner

VIRSell · Feb 24, 2026

Jason O'Byrne

CFO

VIRSell · Feb 24, 2026

Backer Marianne De

CEO

VIRSell · Feb 24, 2026

Verneuil Vanina de

General Counsel

VIRSell · Feb 24, 2026

Brent Sabatini

Principal Accounting Officer

VIRSell · Feb 24, 2026

Explore More Insider Trading Data

VIR Insider Trading Activity

View all insider trades at Vir Biotechnology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity